Prostate cancer is the second-leading cause of cancer death in American men. About 1 in 8 men will be diagnosed with prostate ...

A new study is set to investigate how AI could significantly improve doctors’ decisions regarding prostate cancer treatment. While diagnostic methods for the disease have become safer and more precise ...

The NHS is embarking on a trial that could cut prostate cancer diagnosis times from weeks to a single day. The initiative uses artificial intelligence to analyze MRI scans, potentially transforming ...

England is testing a new artificial intelligence (AI) tool to speed prostate cancer diagnoses, which may save men from weeks of uncertainty about their health. The tool, which will be piloted through ...

FDA-authorized AI tools have the potential to help patients with prostate cancer get clearer answers instead of waiting weeks for genomic test results. FDA-authorized artificial intelligence (AI) ...

The US FDA has granted De Novo marketing authorization for ArteraAI Prostate (Artera, Los Altos, California), a novel artificial intelligence (AI)-powered risk-stratification tool for patients with ...

SYRACUSE, N.Y.--(BUSINESS WIRE)--Associated Medical Professionals (A.M.P.) announced today the availability of the ArteraAI Prostate Test, an AI-powered risk stratification tool to help personalize ...

Digital Health News: Daniel Spratt, chair of radiation oncology at Case Comprehensive Cancer Center, commented on a new AI-enabled prostate cancer risk assessment tool has been developed to analyze ...

PSMA PET-CT is a diagnosit tool helping save men's lives with prostate cancer that has spread beyond the prostate gland Dr. David Samadi says that men with aggressive prostate cancer or a very high ...